28.69 +15.03 (52.53%)
EBS
Stock Details
Last Trade:28.69 Change:+15.03 (52.53%) Prev Close:13.66 Open: 28.61 Days Range:25.00 – 29.98 52 Week Range: 9.15 - 27.00 Volume:444108 P/E: 36.32EPS:0.79
View AllRecent Alerts 07/04/09
Recent Alert on 06/10/09 at 12:45pm
Emergent BioSolutions (EBS) Receives Positive Data From FDA for its BioThrax - Achieves $30 Million Milestone Payment
Emergent BioSolutions (EBS) Receives Positive Data From FDA for its BioThrax - Achieves $30 Million Milestone Payment
Emergent BioSolutions Inc. (NYSE: EBS) announced that BioThrax (Anthrax Vaccine Adsorbed), has been granted a shelf life extension from 3 to 4 years by the U.S. Food and Drug Administration (FDA). Based on this approval, Emergent has achieved a... Read More
Recent Alert on 05/13/09 at 8:27am
Emergent BioSolutions (EBS) Submits to FDA Development Plan for Recombinant Protective Antigen Anthrax Vaccine Candidate
Emergent BioSolutions (EBS) Submits to FDA Development Plan for Recombinant Protective Antigen Anthrax Vaccine Candidate
Recent Alert on 05/13/09 at 8:20am
Emergent BioSolutions (EBS) Submits to FDA Development Plan Required of Bidders in Competitive Range for Recombinant Anthrax Vaccine Contract with HHS
Emergent BioSolutions (EBS) Submits to FDA Development Plan Required of Bidders in Competitive Range for Recombinant Anthrax Vaccine Contract with HHS
Recent Alert on 05/13/09 at 8:20am
Emergent BioSolutions (EBS) Submits to FDA Development Plan Required of Bidders in Competitive Range for Recombinant Anthrax Vaccine Contract with HHS
Emergent BioSolutions (EBS) Submits to FDA Development Plan Required of Bidders in Competitive Range for Recombinant Anthrax Vaccine Contract with HHS
Recent Alert on 04/23/09 at 10:36am
U.S. HHS Issues Additional Amendment to Emergent BioSolutions' (EBS) Proposal for Anthrax rPA Vaccine
U.S. HHS Issues Additional Amendment to Emergent BioSolutions' (EBS) Proposal for Anthrax rPA Vaccine
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
No Recent SEC Filings Available